Chemoinformaics analysis of N-Acetyldehydroanonaine
| Molecular Weight | 305.333 | nRot | 0 |
| Heavy Atom Molecular Weight | 290.213 | nRig | 25 |
| Exact Molecular Weight | 305.105 | nRing | 5 |
| Solubility: LogS | -6.976 | nHRing | 2 |
| Solubility: LogP | 4.557 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 3 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 16 |
| nHA | 3 | APOL | 45.2379 |
| nHD | 0 | BPOL | 21.0981 |
| QED | 0.595 |
| Synth | 2.604 |
| Natural Product Likeliness | 0.602 |
| NR-PPAR-gamma | 0.627 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.958 |
| Pgp-sub | 0.003 |
| HIA | 0.002 |
| CACO-2 | -4.97 |
| MDCK | 0.0000216 |
| BBB | 0.744 |
| PPB | 0.949621 |
| VDSS | 0.976 |
| FU | 0.016393 |
| CYP1A2-inh | 0.982 |
| CYP1A2-sub | 0.491 |
| CYP2c19-inh | 0.965 |
| CYP2c19-sub | 0.424 |
| CYP2c9-inh | 0.759 |
| CYP2c9-sub | 0.909 |
| CYP2d6-inh | 0.926 |
| CYP2d6-sub | 0.764 |
| CYP3a4-inh | 0.866 |
| CYP3a4-sub | 0.435 |
| CL | 5.262 |
| T12 | 0.234 |
| hERG | 0.024 |
| Ames | 0.754 |
| ROA | 0.042 |
| SkinSen | 0.868 |
| Carcinogencity | 0.946 |
| EI | 0.186 |
| Respiratory | 0.405 |
| NR-Aromatase | 0.077 |
| Antiviral | Yes |
| Prediction | 0.782439 |